期刊文献+

Cartilage-targeting peptide-modified dual-drug delivery nanoplatform with NIR laser response for osteoarthritis therapy 被引量:17

原文传递
导出
摘要 Cartilage-targeting delivery of therapeutic agents is still an effective strategy for osteoarthritis(OA)therapy.Recently,scavenging for reactive oxygen species(ROS)and activating autophagy have been increasingly reported to treat OA effectively.In this study,we designed,for the first time,a dual-drug delivery system based on metal organic framework(MOF)-decorated mesoporous polydopamine(MPDA)which composed of rapamycin(Rap)loaded into the mesopores and bilirubin(Br)loaded onto the shell of MOF.The collagen II-targeting peptide(WYRGRL)was then conjugated on the surface of above nanocarrier to develop a cartilage-targeting dual-drug delivery nanoplatform(RB@MPMW).Our results indicated the sequential release of two agents from RB@MPMW could be achieved via near-infrared(NIR)laser irritation.Briefly,the rapid release of Br from the MOF shell exhibited excellent ROS scavenging ability and anti-apoptosis effects,however responsively reduced autophagy activity,to a certain extent.Meanwhile,following the NIR irradiation,Rap was rapidly released from MPDA core and further enhanced autophagy activation and chondrocyte protection.RB@MPMW continuously phosphorylated AMPK and further rescued mitochondrial energy metabolism of chondrocytes following IL-1βstimulation via activating SIRT1-PGC-1αsignaling pathway.Additionally,the cartilage-targeting property of peptide-modified nanocarrier could be monitored via Magnetic Resonance(MR)and IVIS imaging.More significantly,RB@MPMW effectively delayed cartilage degeneration in ACLT rat model.Overall,our findings indicated that the as-prepared dual-drug delivery nanoplatform exerted potent anti-inflammation and anti-apoptotic effects,rescued energy metabolism of chondrocytes in vitro and prevented cartilage degeneration in vivo,which thereby showed positive performance for OA therapy.
出处 《Bioactive Materials》 SCIE 2021年第8期2372-2389,共18页 生物活性材料(英文)
基金 supported by the National Natural Science Foundation of China(81871795,31771048 and 81702124) Shanghai Municipal Health and Family Planning Commission(SHDC12017121) Medical Engineering Cross Research Project of Shanghai Jiaotong University(YG2019QNB37) Songjiang District Science and Technology Research project(18sjkjgg18).
作者简介 These authors contributed equally to this work:Song Xue;These authors contributed equally to this work:Xiaojun Zhou;These authors contributed equally to this work:Weilin Sang;Corresponding author:Libo Zhu,E-mail addresses:zhulibo@medmail.com.cn;Corresponding author:Chuanglong He,E-mail addresses:hcl@dhu.edu.cn;Corresponding author:Jinzhong Ma,E-mail addresses:majinzhong1963@sina.com。
  • 相关文献

同被引文献75

引证文献17

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部